|
Originally published In Press as doi:10.1074/jbc.M206330200 on October 8, 2002
J. Biol. Chem., Vol. 277, Issue 49, 47136-47148, December 6, 2002
Identification of Three NFAT Binding Motifs in the
5'-Upstream Region of the Human CD3 Gene That
Differentially Bind NFATc1, NFATc2, and NF- B p50*
Bassam M.
Badran ,
Steven M.
Wolinsky§,
Arsène
Burny , and
Karen E.
Willard-Gallo ¶
From the Laboratory of Experimental Hematology,
Faculty of Medicine, University of Brussels, 121 Blvd. de Waterloo,
Brussels B1000, Belgium and the § Division of Infectious
Diseases, Department of Medicine, Northwestern University Medical
School, Chicago, Illinois 60611
Human immunodeficiency virus, type 1 (HIV-1)
infection of CD4+ T cells progressively abrogates T
cell receptor (TCR)·CD3 function and surface expression by
specifically interfering with CD3 gene transcription. Our data show that the loss of CD3
transcripts begins very early after infection and accumulates to a
>90% deficiency before a significant effect on surface receptor
density is apparent. Blocking TCR·CD3-directed NFAT activation with
cyclosporin A provokes a partial re-expression of CD3
gene transcripts and surface complexes in a time- and
dose-dependent manner. We have identified three NFAT
consensus sequences (5'-GGAAA-3') in the 5'-upstream region of the
human CD3 gene at: 124 to 120
(NFAT 1), 384 to 380 (NFAT 2), and +450
to +454 (NFAT 3) from the first transcription initiation
site. Using electrophoretic mobility shift and supershift assays, we
show that NFATc2 alone binds to the NFAT 2 motif;
however, complexes containing either NFATc2 or NFATc1 plus NF- B p50
bind to the NFAT 1 and NFAT 3 sites. We
further demonstrate that NFATc1 and NF- B p50 bind in the same
protein·DNA complex and that a fourth Ala added to the core sequence
(5'-GGAAAA-3') in NFAT 1, and
NFAT 3 is critical for their binding. Finally, we have
shown that an increase in the binding of nuclear NFATc2, NFATc1, and
NF- B p50 to these three motifs is correlated with a progressive loss
of CD3 transcripts after HIV-1 infection.
*
This work was supported by grants from the Belgian Fonds
National de la Recherche Scientifique (FNRS-FRSM Grant 3.4584.01 and
FNRS-Télévie Grants 7.4554.01 and 7.4584.01), the European Commission (Grant QLK2-2000-01040), the National Institutes of Health
(Grant HD37356), and a collaborative grant from the International Brachet Foundation (Grant R 97/8-05).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Tel.:
32-2-541-3739; Fax: 32-2-541-3453; E-mail: kwillard@ulb.ac.be.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Xue, P. B. Thippegowda, G. Hu, K. Bachmaier, J. W. Christman, A. B. Malik, and C. Tiruppathi
NF-{kappa}B regulates thrombin-induced ICAM-1 gene expression in cooperation with NFAT by binding to the intronic NF-{kappa}B site in the ICAM-1 gene
Physiol Genomics,
June 1, 2009;
38(1):
42 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tone, Y. Kojima, K. Furuuchi, M. Brady, Y. Yashiro-Ohtani, M. L. Tykocinski, and M. Tone
OX40 Gene Expression Is Up-Regulated by Chromatin Remodeling in Its Promoter Region Containing Sp1/Sp3, YY1, and NF-{kappa}B Binding Sites
J. Immunol.,
August 1, 2007;
179(3):
1760 - 1767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cardoso, V. Durbecq, J.-F. Laes, B. Badran, L. Lagneaux, F. Bex, C. Desmedt, K. Willard-Gallo, J. S. Ross, A. Burny, et al.
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner
Mol. Cancer Ther.,
December 1, 2006;
5(12):
3042 - 3051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Badran, K. Kunstman, J. Stanton, M. Moschitta, A. Zerghe, H. Akl, A. Burny, S. M. Wolinsky, and K. E. Willard-Gallo
Transcriptional Regulation of the Human CD3{gamma} Gene: The TATA-Less CD3{gamma} Promoter Functions via an Initiator and Contiguous Sp-Binding Elements
J. Immunol.,
May 15, 2005;
174(10):
6238 - 6249.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|